← ANALYST RATINGS · TIPRANKS
Sotera Health (SHC): analyst forecast and price target
Analyst consensus
Moderate Buy3 Buy0 Hold1 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $21.75, the highest $24.00, the lowest $17.00. The average is +21.6% from the last price of $17.89.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $17.00 | Sell | −5.0% | Downgrade | 13.10.26on TipRanks Oct 14 06:06 | +0.3%next day −1.6% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $22.00 | Buy | +23.0% | Reiterated | 07.10.26on TipRanks 04:00 | −1.7%next day 0.0% · 5 days 0.0% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $24.00 | Buy | +34.2% | Reiterated | 06.10.26on TipRanks 21:45 | −1.7%next day 0.0% · 5 days 0.0% | ↗ |
| Evie Koslosky★★★★★★★★★★#9740 · hits 58% · avg −3.1% | Goldman Sachs | $24.00 | Buy | +34.2% | Reiterated | 20.09.26on TipRanks Sep 21 08:15 | −1.7%next day 0.0% · 5 days −0.3% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $25.00 | Buy | +39.7% | Reiterated | 18.09.26on TipRanks 07:45 | −1.3%next day −1.7% · 5 days −3.4% | ↗ |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $20.00 → $21.00+5.0% | Buy | +17.4% | Reiterated | 07.08.26on TipRanks 11:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $19.50 → $21.50+10.3% | Buy | +20.2% | Reiterated | 07.08.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $18.00 → $19.00+5.6% | Hold | +6.2% | Reiterated | 07.08.26on TipRanks 11:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $19.50 → $21.50+10.3% | Buy | +20.2% | Upgrade | 07.08.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $19.00 → $20.50+7.9% | Hold | +14.6% | Reiterated | 07.08.26on TipRanks 11:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $20.00 | Hold | +11.8% | Downgrade | 07.08.26on TipRanks 11:05 | — | |
| Name not given | — | $23.00 → $25.00+8.7% | Buy | +39.7% | Reiterated | 07.08.26on TipRanks 07:01 | −0.9%next day +0.6% · 5 days −0.2% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $20.00 → $22.00+10.0% | Buy | +23.0% | Assigned | 06.08.26on TipRanks Aug 7 08:10 | +5.3%next day −0.9% · 5 days −0.6% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $19.50 | Buy | +9.0% | Reiterated | 20.11.25on TipRanks 09:00 | +1.6%next day +2.4% · 5 days +6.0% | ↗ |
| Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% | KeyBanc | — | Hold | — | Reiterated | 05.11.25on TipRanks 04:00 | −4.1%next day +2.3% · 5 days +1.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Sotera Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 06.10.26: target $22.86 at a price of $18.55 (+23.2%); now: $22.71 at $17.89 (+27.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 0 | 0 | 0 |
| Buy | 6 | 8 | 7 | 7 | 6 | 6 |
| Hold | 0 | 1 | 1 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
Earnings and sales forecast
Next report: 10.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.27 (from $0.26 to $0.27). Last quarter: $0.26.
Sales
Next quarter’s sales estimate — $320M (from $317M to $325M). Last quarter: $321M.
Best top-analyst consensus in the sector · Healthcare
About Sotera Health
- CEO: Alton E. Shader
- Employees: 3,000
- 9100 South Hills Boulevard, Broadview Heights, OH, 44147, US
- soterahealth.com
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Data from the stock’s TipRanks forecast page, read 61 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗